Related Content
September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...
July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson's disease (PD).
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation ...
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.
World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and people ...
December 19, 2016 — Children’s National Health System and Celsion Corp. announced in November the launch of a clinical ...
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use ...
September 12, 2016 — Tiny microbubbles are being used to more effectively identify liver tumors, according to a study ...